ArticleJACC. Case reports2026
TAVI in Patient With Severe Aortic Regurgitation and Previous Mechanical Mitral and Tricuspid Valve Prostheses.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter aortic valve implantation is technically challenging in patients with predominant aortic regurgitation and preexisting mitral prosthetic heart valve. CASE SUMMARY: To the best of our knowledge, this is the first reported case in which transcatheter aortic valve implantation was successfully performed for predominant severe aortic regurgitation with a history of 3 prior sternotomies: successively for mitral valve replacement with a Starr-Edwards valve, tricuspid valve repair, and subsequently tricuspid valve replacement. DISCUSSION: This patient had large aortic annulus dimensions. Noticing predominant aortic regurgitation and mild valvular calcium, we were aiming at 15% to 20% oversizing of the transcatheter valve, which was achievable by overfilling the largest balloon-expandable valve. Having an incomplete understanding of potential aortomitral interaction based on computed tomography and echocardiography, we inflated a balloon at the aortic valve, which revealed significant interaction, leading us to use a self-expanding valve that had limited oversizing. TAKE-HOME MESSAGE: Identifying the aortomitral interaction in such cases can potentially avoid transcatheter aortic valve embolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.